SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009615
Filing Date
2017-05-09
Accepted
2017-05-09 08:02:55
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q agle-10q_20170331.htm 10-Q 1485924
2 EX-10.1 agle-ex101_287.htm EX-10.1 100794
3 EX-31.1 agle-ex311_65.htm EX-31.1 14741
4 EX-31.2 agle-ex312_66.htm EX-31.2 14300
5 EX-32.1 agle-ex321_67.htm EX-32.1 6987
6 EX-32.2 agle-ex322_68.htm EX-32.2 6913
  Complete submission text file 0001564590-17-009615.txt   5023554

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT agle-20170331.xml EX-101.INS 947587
8 XBRL TAXONOMY EXTENSION SCHEMA agle-20170331.xsd EX-101.SCH 43306
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agle-20170331_cal.xml EX-101.CAL 37919
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agle-20170331_def.xml EX-101.DEF 121210
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20170331_lab.xml EX-101.LAB 297208
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20170331_pre.xml EX-101.PRE 228772
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 17824705
SIC: 2834 Pharmaceutical Preparations